Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating Immunogenicity and Safety Effect on Combined Immune Effect of EV71 Inactivated Vaccine and HepB、MPSV-A、MR、JE-L：A Multi-center Randomized Controlled Trial

NCT03519568 is registered in ClinicalTrials.gov with Shandong Province Centers for Disease Control and Prevention as lead sponsor.

NCT NCT03519568
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03519568 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating Immunogenicity and Safety Effect on Combined Immune Effect of EV71 Inactivated Vaccine and HepB、MPSV-A、MR、JE-L：A Multi-center Randomized Controlled Trial
Lead sponsor
Shandong Province Centers for Disease Control and Prevention
Phase
Phase 4
Overall status
Unknown status
Start date
March 1, 2018
Completion date
April 30, 2019
Enrollment
1,944 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

enterovirus 71 inactivated vaccine, hfmd